Double Blind Randomized Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis Stage 1 and 2
Phase of Trial: Phase III
Latest Information Update: 22 May 2017
Price : $35 *
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteonecrosis
- Focus Therapeutic Use
- 15 May 2017 Status changed from recruiting to discontinued because of Troubles recruiting patients.
- 03 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 30 Jun 2014 New trial record